Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPA’s TruLabel program

This article was originally published in The Tan Sheet

Executive Summary

The Vitamin Shoppe's Body Tech 100% Pure Creatine caps and Now Foods Creatine Monohydrate 750 mg were among eight popular sports supplements found to contain no steroids or stimulants in the first independent lab test conducted under the Natural Products Association's TruLabel program, the association announces March 9. "This should give continued confidence to sports dietary supplement users that what's on the label is what's in the bottle; nothing more, nothing less," NPA says. Under the TruLabel program, supplements are randomly chosen for testing to ensure label and ingredient authenticity and accuracy; more than 23,000 product labels are currently registered as part of the program (1"The Tan Sheet" July 24, 2006, p. 6)...

You may also be interested in...



States’ Steps Against Supplements Overlook Federal Oversight – Attorneys

State regulatory activity against dietary supplements poses a threat that requires a unified front from the industry, two food and drug attorneys say

NPA’s TruLabel Program Expands To Ensure Purity Of Sports Supplements

The Natural Products Association is expanding testing in its TruLabel verification program to assure consumers that the products "are without traces of banned steroidal and stimulant ingredients.

Prices Plunge As Xarelto Generics Arrive In India

More than half a dozen generic rivaroxaban brands are now available in India, putting the heat on Bayer’s blockbuster anticoagulant Xarelto in the price-sensitive market. Many rival generics are priced over 50% lower than the innovator product.

Topics

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel